期刊文献+

泮托拉唑及奥美拉唑对氯吡格雷抗血小板效应的影响 被引量:1

下载PDF
导出
摘要 目的:探讨泮托拉唑及奥美拉唑对氯吡格雷抗血小板聚集的影响。方法:选取我院心内科冠脉综合征患者210例,随机分为泮托拉唑组和奥美拉唑组各105例,对两组患者均在阿司匹林和氯吡格雷双联抗血小板治疗的基础上分别给予泮托拉唑和奥美拉唑,比较治疗前后两组患者血小板反应性指数(PRO、血小板聚集率(ADP-ag)及主要心血管不良事件。结果:奥美拉唑组治疗后7天PRI及ADP-Ag数值均明显下降,泮托拉唑组治疗7天后ADP-Ag数值亦显著下降,但PRI与治疗前比较下降不明显。两组患者治疗后7天时PRI及ADP-Ag数值两组问比较差异无统计学意义(P〉0.05);两组均无主要心血管不良事件发生。结论:泮托拉唑对氯吡格雷的抗血小板治疗具有抑制作用,但不至引起临床心血管事件发生,奥美拉唑对双联抗血小板治疗效应无明显影响。
作者 陈倩
出处 《中国中医药咨讯》 2012年第3期65-66,共2页
  • 相关文献

参考文献5

二级参考文献30

  • 1CHANCE研究组.无保护左主干病变支架置入术预后及影响因素的分析——中国无保护左主干病变支架置入术注册(CHANCE)研究[J].中华心血管病杂志,2005,33(3):210-215. 被引量:19
  • 2韩雅玲,王耿,荆全民,王守力,王祖禄,王冬梅,马颖艳,栾波.急性冠状动脉综合征介入治疗4670例近期疗效的评价[J].中华医学杂志,2005,85(15):1040-1044. 被引量:47
  • 3Eric L Eisenstein, DBA,Kevin J. Anstrom, PhD,David F. Kong, MD,Linda K. Shaw, MS,Robert H. Tuttle, MSPH,Daniel B. Mark, MD, MPH,Judith M. Kramer, MD, MS,Robert A. Harrington, MD,David B. Matchar, MD,David E. Kandzari, MD 1,Eric D. Peterson, MD, MPH,Kevin A. Schulman, MD,Robert M. Califf, MD,李呈亿(译),David E. Kandzari, MD.氯吡格雷的使用与药物洗脱支架植入后远期临床结果[J].美国医学会杂志(中文版),2007,26(3):131-139. 被引量:59
  • 4Juurlink DN, Gomes T, Ko DT, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel [J] .CMAJ, 2009, 180 (7): 713-718.
  • 5Ho PM, Maddox TM, Wang L, et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome [ J ] . JAMA, 2009, 301 ( 9 ) : 937-944.
  • 6Sibbing D, Morath T, Stegherr J, et al. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel [ J ] . Thromb Haemost, 2009, 101 (4) : 714-719.
  • 7Mehta SR, Yusuf S, Peters R J, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention : the PCI-CURE study [ J ] . Lancet, 2001, 358 (9281) : 527-533.
  • 8Derry S, Loke YK. Risk of gastrointestinal haemorrhage with long term use of aspirin : meta-analysis [ J ] . BMJ, 2000, 321 ( 7270 ): 1183-1187.
  • 9O'Donoghue ML, Braunwald E, Antman EM, et al. Pharmacody- namic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor : an analysis of two randomised trials [ J ] . Lancet, 2009, 374 ( 9694 ) : 989-997.
  • 10O'Donoghue M, Antman EM, Braunwald E, et al. The efficacy and safety of prasugrel with and without a glycoprotein Ⅱb/Ⅲa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention : a TRITON-TIMI 38(Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis [ J ] . J Am Coil Cardiol, 2009, 54 ( 8 ) : 678-685.

共引文献561

同被引文献11

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部